Drugs / TI Inhalation Powder
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00747006 | Sep 2008 → Feb 2011 | type 1 diabetes mellitus, type 2 diabetes mellitus | Mannkind Corporation | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TI Inhalation Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00747006 ↗ |
| Known as | Technosphere Insulin Inhalation Powder | “Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)” NCT00747006 ↗ |
| Route | Inhaled | “Inhaled insulin technology to be administered immediately before a meal” NCT00747006 ↗ |